GlassScriptPhysician profile
Yu Chuan Liu
NPI 1689740169
$2,308.50
in general payments reported to CMS, 2019-2025
9 companies · $588 in 2025
The $588 reported for 2025 was more than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $460 · 2020: $218 · 2021: $245 · 2022: $203 · 2023: $290 · 2024: $305 · 2025: $588.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,182.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,182.43 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $923.81 | 2019-2024 | Assurity |
| Medtronic, INC. | $566.65 | 2022-2025 | Selectsecure, Micra, Cobalt Dr Mri Surescan |
| Biotronik INC. | $292.86 | 2025 | |
| Boston Scientific Corporation | $224.90 | 2019-2022 | |
| Edwards Lifesciences Corporation | $177.40 | 2024 | Edwards Sapien 3 Transcatheter Heart Valve (Thv) |
| E.R. Squibb & Sons, L.L.C. | $53.33 | 2025 | Eliquis |
| Medtronic Vascular, INC. | $36.77 | 2019-2020 | |
| Lantheus Medical Imaging, INC. | $19.14 | 2024 | |
| Regeneron Healthcare Solutions, INC. | $13.64 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Yu Chuan Liu listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.